Download PDF
Arzneimittelforschung 2012; 62(05): e1
DOI: 10.1055/s-0032-1306332
Erratum
© Georg Thieme Verlag KG Stuttgart · New York

The Multidrug Resistant Modulator HZ08 Reverses Multidrug Resistance via P-glycoprotein Inhibition and Apoptosis Sensitization in Human Epidermoid Carcinoma Cell Line KBv200

Y.-L. Zhu
1   Department of Physiology, China Pharmaceutical University, Nanjing, P. R. China
,
J. Cen
2   Key Laboratory of Nature Medicine and Immune Engineering, Henan University, Kaifeng, P. R. China
,
Y.-Y. Zhang
1   Department of Physiology, China Pharmaceutical University, Nanjing, P. R. China
,
Y.-D. Feng
1   Department of Physiology, China Pharmaceutical University, Nanjing, P. R. China
,
Y. Yang
1   Department of Physiology, China Pharmaceutical University, Nanjing, P. R. China
,
Y.-M. Li
1   Department of Physiology, China Pharmaceutical University, Nanjing, P. R. China
,
W.-L. Huang
3   Center of Drug Discovery, China Pharmaceutical University, Nanjing, P. R. China
› Author Affiliations
Further Information

Publication History

Publication Date:
27 February 2012 (online)

    Permissions and Reprints

Correction to:

The Multidrug Resistant Modulator HZ08 Reverses Multidrug Resistance via P-glycoprotein Inhibition and Apoptosis Sensitization in Human Epidermoid Carcinoma Cell Line KBv200Arzneimittelforschung 2012; 62(05): 236-242
DOI: 10.1055/s-0031-1301344

Erratum

The Multidrug Resistant Modulator HZ08 Reverses Multidrug Resistance via P-glycoprotein Inhibition and Apoptosis Sensitization in Human Epidermoid Carcinoma Cell Line KBv200

Y.-L. Zhu, J. Cen, Y.-Y. Zhang, Y.-D. Feng, Y. Yang, Y.-M. Li, W.-L. Huang

Arzneimittelforschung 2012; 62: Published online: 2012

DOI: 10.1055/s-0031-1301344

The Affiliations of J.Cen and figure 2 were changed.